Understanding the Emergence of Anaplasmosis Associated Myopericarditis

Human granulocytic anaplasmosis (HGA) is a tick-borne zoonotic disease caused by the obligate intracellular bacterium Anaplasma phagocytophilum. While many clinicians associate tick-borne illnesses primarily with Lyme disease, the incidence of HGA has risen significantly over the past decade. Traditionally, anaplasmosis presents as a non-specific febrile illness characterized by fever, chills, and myalgia. However, recent clinical evidence has highlighted life-threatening complications, including anaplasmosis associated myopericarditis. This rare cardiovascular manifestation requires prompt recognition because it is highly treatable with specific antibiotic therapy. Therefore, understanding the intersection of infectious disease and cardiology is becoming increasingly vital for hospitalists and emergency physicians alike. In a recently reported case, a previously healthy 28-year-old man presented with acute chest pain and ventricular arrhythmias. Initially, the cause of his cardiac inflammation was unclear, but further investigation revealed an acute HGA infection. Consequently, this case underscores the importance of considering atypical pathogens in the differential diagnosis of myopericarditis. Furthermore, since the vectors for these diseases are expanding geographically, medical professionals must remain vigilant. Early identification can prevent severe outcomes, as the inflammation often resolves completely with the correct intervention. By integrating tick-borne disease screening into cardiac workups, clinicians can ensure that patients receive targeted care rather than just symptomatic management.

Pathophysiology of Cardiac Inflammation in HGA

The mechanism by which Anaplasma phagocytophilum induces myocardial and pericardial inflammation is complex and multifaceted. Unlike some viral causes of myocarditis that directly invade myocytes, HGA typically involves a robust systemic inflammatory response. The pathogen primarily infects neutrophils, where it resides in cytoplasmic vacuoles known as morulae. Consequently, this infection triggers the release of various pro-inflammatory cytokines and chemokines. These mediators can lead to a hyperinflammatory state that inadvertently affects cardiac tissue. Additionally, histopathological studies in fatal cases have sometimes shown neutrophilic and lymphocytic infiltrates within the myocardium. This suggests that the immune system's attempt to clear the bacterial load might contribute to collateral damage in the heart. Moreover, the bacteria can cause endothelial dysfunction and microvascular injury, which might further exacerbate cardiac strain. Therefore, the resulting myopericarditis is likely a combination of direct bacterial presence and an overactive host immune response. Physicians should note that while isolated HGA is rare, its ability to cause hemodynamic instability is well-documented in medical literature. Understanding these pathways is essential for appreciating why standard cardiac treatments may be insufficient without addressing the underlying bacterial infection. Thus, the physiological link between the tick-borne pathogen and the heart remains a critical area for ongoing clinical education and research.

Clinical Presentation and Diagnostic Red Flags

Patients with cardiac involvement due to anaplasmosis often present with symptoms that mimic other forms of acute coronary syndrome or viral myocarditis. Common complaints include sharp, pleuritic chest pain, dyspnea, and palpitations. In many cases, these symptoms are accompanied by high fever and severe malaise, which should immediately raise suspicion of an underlying infection. Laboratory findings are particularly revealing in HGA. Clinicians should look for the "classic triad" of leukopenia, thrombocytopenia, and mild to moderate elevations in liver transaminases. These hematologic abnormalities are quite distinct from the typical leukocytosis seen in many other bacterial infections. Furthermore, an electrocardiogram (ECG) may show diffuse ST-segment elevations or PR-segment depressions consistent with pericarditis. Some patients also develop rhythm disturbances, such as ventricular arrhythmias or atrial fibrillation. To confirm the diagnosis, polymerase chain reaction (PCR) testing of whole blood is the gold standard during the acute phase. Serology for IgM and IgG antibodies can also be used, though these often require convalescent testing for definitive confirmation. Additionally, a peripheral blood smear may occasionally show morulae within neutrophils, providing a quick visual diagnostic clue. Therefore, clinicians must maintain a high index of suspicion, especially when a patient reports recent outdoor activity or tick exposure during the spring or summer months.

Distinguishing HGA from Lyme Carditis

A significant challenge in diagnosing tick-borne cardiac issues is the overlapping endemicity of HGA and Lyme disease. Both infections are transmitted by the Ixodes tick, and co-infections are relatively common. However, the cardiac manifestations of these two diseases differ significantly. Lyme carditis typically presents with conduction system disturbances, most notably atrioventricular (AV) blocks that can progress rapidly to third-degree block. In contrast, anaplasmosis associated myopericarditis is characterized more by direct inflammation of the muscle and pericardium, leading to chest pain and elevated troponin levels. While Lyme disease often presents with the classic erythema migrans rash, HGA rarely causes skin manifestations. This lack of a rash can make HGA harder to identify if the clinician is only looking for typical tick-borne signs. Moreover, because the treatment for both includes doxycycline, empiric therapy is often started before a definitive diagnosis is made. Nevertheless, identifying the specific pathogen is crucial for determining the necessary duration of treatment and monitoring for other complications. Consequently, a comprehensive tick-borne panel that includes both Borrelia burgdorferi and Anaplasma phagocytophilum is recommended. This thorough approach ensures that the specific nuances of the infection are addressed, leading to better patient outcomes and more accurate epidemiological tracking.

Managing Anaplasmosis Associated Myopericarditis with Doxycycline

The primary treatment for all forms of HGA, including those involving the heart, is doxycycline. This tetracycline antibiotic is highly effective against the intracellular Anaplasma species and remains the first-line recommendation for both adults and children. In most cases, patients show dramatic clinical improvement within 24 to 48 hours of starting the medication. For cases of anaplasmosis associated myopericarditis, the standard dosage is typically 100 mg twice daily, administered either orally or intravenously depending on the patient's stability. The duration of therapy generally ranges from 10 to 14 days to ensure complete eradication of the pathogen and to cover any potential co-infection with Lyme disease. Furthermore, supportive care for the cardiac symptoms is essential. This may include the use of non-steroidal anti-inflammatory drugs (NSAIDs) for pericarditic pain or anti-arrhythmic agents if needed. However, the most critical factor for recovery is the timely initiation of antibiotics. Delaying treatment while waiting for laboratory confirmation can lead to worsening cardiac function or systemic shock. Therefore, if the clinical picture and laboratory markers suggest a tick-borne etiology, empiric doxycycline should be started immediately. Most patients, like the 28-year-old man in the recent case report, achieve a full recovery with no lasting cardiac sequelae after completing the antibiotic course. This highlight's the importance of early intervention in managing this treatable cause of myopericarditis.

Global Vigilance and the Future of Tick-Borne Cardiology

As the range of tick vectors continues to expand due to climate change and ecological shifts, the geographic footprint of anaplasmosis is growing. What was once considered a regional disease in the Northeast United States is now being diagnosed more frequently in Canada, Europe, and parts of Asia. In India, where other rickettsial infections are endemic, the potential for HGA to be an under-recognized cause of febrile illness and myocarditis is significant. Clinicians worldwide must adapt their diagnostic algorithms to include tick-borne pathogens in patients presenting with unexplained cardiac inflammation. Additionally, public health education regarding tick bite prevention remains a cornerstone of reducing the disease burden. Moreover, continued research into the long-term cardiac effects of these infections is necessary to refine follow-up protocols. While most patients recover fully, the potential for severe hemodynamic compromise necessitates a high level of clinical vigilance. By sharing case reports and literature reviews, the medical community can better prepare for the increasing frequency of these uncommon complications. Ultimately, a multidisciplinary approach involving cardiologists and infectious disease specialists will provide the best care for patients facing the diverse challenges of tick-borne illnesses.

Frequently Asked Questions

How can a clinician distinguish HGA from a common viral myocarditis?

Distinguishing HGA from viral myocarditis relies heavily on laboratory markers and patient history. While both cause chest pain and troponin elevation, HGA is uniquely associated with leukopenia, thrombocytopenia, and elevated liver enzymes. Additionally, a history of tick exposure or travel to endemic regions during peak tick season provides a strong clue. PCR testing for Anaplasma DNA can provide a definitive diagnosis that viral panels may miss.

Is doxycycline safe for patients with severe cardiac involvement from anaplasmosis?

Yes, doxycycline is the gold standard treatment and is considered safe and essential for these patients. Even in cases involving hemodynamic instability or arrhythmias, the antibiotic should be started promptly to address the underlying cause of inflammation. It is generally well-tolerated, and the rapid response of Anaplasma to this medication often leads to a quick stabilization of the patient's cardiovascular status within the first few days.

What is the long-term prognosis for patients who recover from HGA-related myopericarditis?

The long-term prognosis for patients who receive timely treatment is excellent. Most clinical cases, including the one reviewed here, report a complete resolution of cardiac inflammation and electrical disturbances without permanent damage to the heart muscle. However, follow-up with a cardiologist is often recommended to ensure that ventricular function has returned to normal and that there are no lingering inflammatory changes visible on echocardiography or cardiac MRI.

Disclaimer: This content is for informational and educational purposes only. It is not intended to provide specific medical advice or to take the place of advice from your personal physician or another healthcare professional. Refer to the latest local and national guidelines for clinical practice.

References

Nwokeocha S et al. Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis. J Med Case Rep. 2026 Jul 15. doi: 10.1186/s13256-026-06385-1. PMID: 42458509.

Centers for Disease Control and Prevention (CDC). Anaplasmosis: Information for Healthcare Providers. https://www.cdc.gov/anaplasmosis/hcp/clinical-care/index.html.

Biggs HM, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States: A Practical Guide for Health Care and Public Health Professionals. MMWR Recomm Rep 2016;65(No. RR-2):1–44.